Literature DB >> 20670227

Fifty years of paediatric malignant bone tumours in the West Midlands, UK, 1957-2006: incidence, treatment and outcome.

S E Parkes1, S Parke, D C Mangham, R J Grimer, P Davies, B J Morland.   

Abstract

Malignant bone tumours in the paediatric age group (0-14 years) are uncommon; various aetiological theories exist and few reports of incidence, age and sex distributions have been published. We examined the incidence of childhood malignant bone tumours in one large single region of the UK over an extended period of 50 years. The West Midlands specialist regional children's tumour registry holds data on all malignancies and benign brain tumours in children under 15 years in the West Midlands region, which has a population of around 1 million children. Demographic and clinical data have been abstracted and diagnoses reviewed by a panel of expert pathologists. During the period 1957-2006, 259 cases of malignant paediatric bone tumours were diagnosed. There were 153 osteosarcomas, 78 Ewing sarcomas and 28 other primary bone tumours. The overall age standardised rate was 4.66, with no increase over time, although there was a significant increase in the incidence of Ewing sarcomas in the period 1965-92. Sixty-eight per cent of tumours were in patients over 10 years, whereas the incidence in patients under 10 years showed a non-significant increase. Survival rates increased dramatically post-chemotherapy introduction, with Ewing sarcoma demonstrating better survival overall. This is a large study giving an overview of malignant bone tumours in the childhood population of a single region over an extended period, showing results consistent with national reports. It also examines late effects, which were mostly mobility/orthopaedic, although almost one-fifth of patients had cardiac problems and five went on to develop second malignancies.

Entities:  

Mesh:

Year:  2010        PMID: 20670227     DOI: 10.1111/j.1365-3016.2010.01130.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  4 in total

1.  Focal adhesion kinase is involved in the migration of human osteosarcoma cells.

Authors:  Sitan Feng; Xin Shi; K E Ren; Sujia Wu; Xiaoliang Sun
Journal:  Oncol Lett       Date:  2015-04-21       Impact factor: 2.967

2.  Paley's multiplier method does not accurately predict adult height in children with bone sarcoma.

Authors:  Magdalena Maria Gilg; Christine Wibmer; Dimosthenis Andreou; Alexander Avian; Petra Sovinz; Werner Maurer-Ertl; Per-Ulf Tunn; Andreas Leithner
Journal:  Clin Orthop Relat Res       Date:  2014-04-29       Impact factor: 4.176

3.  Focal adhesion kinase overexpression and its impact on human osteosarcoma.

Authors:  Ke Ren; Xiao Lu; Nan Yao; Yong Chen; Aizhen Yang; Hui Chen; Jian Zhang; Sujia Wu; Xin Shi; Chen Wang; Xiaoliang Sun
Journal:  Oncotarget       Date:  2015-10-13

4.  Focal adhesion kinase promotes progression and predicts poor clinical outcomes in patients with osteosarcoma.

Authors:  Hua-Jie Gu; Bin Zhou
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.